Literature DB >> 31475512

Acute Graft-Versus-Host Disease: A Brief Review

Elifcan Aladağ1, Engin Kelkitli2, Hakan Göker1.   

Abstract

Graft‐versus‐host disease (GvHD) is an important complication that can be observed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Acute GvHD (aGvHD) is seen after allo-HSCT and the incidence of aGvHD is around 30%-50%. aGvHD prophylaxis is essential in patients undergoing allo-HSCT. Initial therapy for aGvHD is steroids. Prognosis is poor in aGvHD patients not responding to steroids. In this article, the pathobiology, clinical findings, prophylaxis, and treatment of aGvHD will be summarized.

Entities:  

Keywords:  Graft-versus-host disease; Acute; Chronic

Year:  2019        PMID： 31475512     DOI： 10.4274/tjh.galenos.2019.2019.0157

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN： 1300-7777            Impact factor:   1.831


  6 in total

1.  Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease.

Authors:  Xiaoying Qiao; Jarosław Biliński; Leyi Wang; Tianyu Yang; Rongmu Luo; Yi Fu; Guibin Yang
Journal:  Bone Marrow Transplant       Date:  2022-09-27       Impact factor: 5.174

Review 2.  A bibliometric analysis of global publications on graft-versus-host disease research.

Authors:  Xuemiao Huang; Taiwei Wang; Wanting Zu; Tianxin Xu; Lin Du; Yiming Wang; Wenbo Nie; Lisheng Wang
Journal:  Medicine (Baltimore)       Date:  2022-07-08       Impact factor: 1.817

Review 3.  A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD.

Authors:  Jiahua Li; Xueyan Zhang; Yiru Chen; Qingqing Zheng; Mingyi Zhao; Hua Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-05-05       Impact factor: 7.310

4.  The Potential Genes Mediate the Pathogenicity of Allogeneic CD4+T Cell in aGVHD Mouse Model.

Authors:  Zhengyu Yu; Chenchen Qin; Min Cao; Xiaoya He; Hanyun Ren; Huihui Liu
Journal:  Biomed Res Int       Date:  2021-05-07       Impact factor: 3.411

5.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

6.  Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Authors:  Elifcan Aladağ Karakulak; Haluk Demİroğlu; Umit Yavuz Malkan; Umit Akman; Hakan Göker; Yahya Büyükaşik
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.